Sirtex Medical Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sirtex Medical Limited with three other
miscellaneous service companies in Australasia:
Xrf Scientific Ltd
sales of 21.13 million Australian Dollars [US$16.32 million]
of which 43%
was Precious Metals),
(18.57 million Australian Dollars [US$14.34 million]
of which 80%
was Bronchitol and Aridol), and
(58.52 million Australian Dollars [US$45.19 million]
of which 100%
was Mesenchymal Precursor Cell).
During the year ended June of 2016, sales at
Sirtex Medical Limited were A$232.49 million (US$179.53 million).
increase of 32.0%
versus 2015, when the company's sales were A$176.09 million.
This was the fifth consecutive year of sales increases at Sirtex Medical Limited
(and since 2011, sales have increased a total of 231%).